Page last updated: 2024-10-30

metformin and Ocular Hypertension

metformin has been researched along with Ocular Hypertension in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Ocular Hypertension: A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Xu, L1
Zhang, X1
Zhao, Y1
Gang, X1
Zhou, T1
Han, J1
Cao, Y1
Qi, B1
Song, S1
Wang, X1
Liang, Y1
Ma, J1
Liu, W1
Hunter, A1
Zhang, W1

Other Studies

2 other studies available for metformin and Ocular Hypertension

ArticleYear
Metformin protects trabecular meshwork against oxidative injury via activating integrin/ROCK signals.
    eLife, 2023, 01-04, Volume: 12

    Topics: Animals; Cells, Cultured; Glaucoma; Glaucoma, Open-Angle; Humans; Integrins; Metformin; Mice; Ocular

2023
Performing meta-analysis with incomplete statistical information in clinical trials.
    BMC medical research methodology, 2008, Aug-18, Volume: 8

    Topics: Antihypertensive Agents; Cholesterol, LDL; Clinical Trials as Topic; Data Interpretation, Statistica

2008